Social anxiety disorder

Social anxiety disorder
Other namesSocial phobia
SpecialtyPsychiatry, clinical psychology
Symptoms
Usual onsetTypically during adolescence
Risk factors
  • Genetic factors
  • Preexisting mental disorder
Treatment Gabapentin
Frequency7% (2003)[1] to 36% (2020)[2]
Social anxiety disorder is distinct from the personality traits of introversion and shyness.[3][4]

Social anxiety disorder (SAD), also known as social phobia, is an anxiety disorder characterized by sentiments of fear and anxiety in social situations, causing considerable distress and impairing ability to function in at least some aspects of daily life.[5][6][7] These fears can be triggered by perceived or actual scrutiny from others. Individuals with social anxiety disorder fear negative evaluations from other people.

Physical symptoms often include excessive blushing, excessive sweating, trembling, palpitations, rapid heartbeat, muscle tension, shortness of breath, and nausea.[8] Panic attacks can also occur under intense fear and discomfort. Some affected individuals may use alcohol or other drugs to reduce fears and inhibitions at social events. It is common for those with social phobia to self-medicate in this fashion, especially if they are undiagnosed, untreated, or both; this can lead to alcohol use disorder, eating disorders or other kinds of substance use disorders. According to ICD-10 guidelines, the main diagnostic criteria of social phobia are fear of being the focus of attention, or fear of behaving in a way that will be embarrassing or humiliating, avoidance and anxiety symptoms.[9] Standardized rating scales can be used to screen for social anxiety disorder and measure the severity of anxiety.

The first line of treatment for social anxiety disorder is cognitive behavioral therapy (CBT).[5][6][10] CBT is effective in treating this disorder, whether delivered individually or in a group setting.[11] The cognitive and behavioral components seek to change thought patterns and physical reactions to anxiety-inducing situations.

The attention given to social anxiety disorder has significantly increased since 1999 with the approval and marketing of drugs for its treatment. Prescribed medications include several classes of antidepressants: selective serotonin reuptake inhibitors (SSRIs), serotonin–norepinephrine reuptake inhibitors (SNRIs), and monoamine oxidase inhibitors (MAOIs).[12] Other commonly used medications include beta blockers and benzodiazepines. Medications such as SSRIs are effective for social phobia, such as paroxetine.[6][13][14]

  1. ^ "Social Anxiety Disorder". National Institute of Mental Health, US National Institutes of Health. 2025. Retrieved 5 March 2025.
  2. ^ Jefferies P, Ungar M (2020). "Social anxiety in young people: A prevalence study in seven countries". PLOS One. 15 (9): e0239133. Bibcode:2020PLoSO..1539133J. doi:10.1371/journal.pone.0239133. PMC 7498107. PMID 32941482.
  3. ^ Peterson AL (11 April 2019). "Introversion, Shyness & Social Anxiety: What's the Difference?". Mental Health at Home. Archived from the original on 1 August 2022.
  4. ^ Brown A (13 March 2022). "Social Anxiety? Introvert? Or Shy?". Mind Journal. Archived from the original on 1 August 2022.
  5. ^ a b "Social Anxiety Disorder: Recognition, Assessment, and Treatment". National Institute for Health and Clinical Excellence. 2025. Retrieved 12 March 2025.
  6. ^ a b c Rose GM, Tadi P (25 October 2022). "Social Anxiety Disorder". StatPearls, US National Library of Medicine. Retrieved 13 March 2025.
  7. ^ "Social Anxiety Disorder: More Than Just Shyness". National Institute of Mental Health, US National Institutes of Health. 2022. Retrieved 13 March 2025.
  8. ^ "Social anxiety disorder (social phobia)". Mayo Clinic. 19 June 2021. Retrieved 5 March 2025.
  9. ^ Social Phobia (F40.1) in ICD-10: Diagnostic Criteria and Clinical descriptions and guidelines.
  10. ^ Pilling S, Mayo-Wilson, E, Mavranezouli, I, et al. (22 May 2013). "Recognition, assessment and treatment of social anxiety disorder: summary of NICE guidance" (PDF). BMJ (Clinical Research Ed.). 346: f2541. doi:10.1136/bmj.f2541. PMID 23697669. S2CID 13776769.
  11. ^ Hofmann SG, Smits JA (2008). "Cognitive-behavioral therapy for adult anxiety disorders: A meta-analysis of randomized placebo-controlled trials". The Journal of Clinical Psychiatry. 69 (4): 621–632. doi:10.4088/JCP.v69n0415. PMC 2409267. PMID 18363421.
  12. ^ Blanco C, Bragdon LB, Schneier FR, et al. (2012). "The evidence-based pharmacotherapy of social anxiety disorder". The International Journal of Neuropsychopharmacology. 16 (1): 235–249. doi:10.1017/S1461145712000119. PMID 22436306.
  13. ^ Liebowitz MR, Schneier FR, Bragdon LB, et al. (1 February 2013). "The evidence-based pharmacotherapy of social anxiety disorder". International Journal of Neuropsychopharmacology. 16 (1): 235–249. doi:10.1017/S1461145712000119. ISSN 1461-1457. PMID 22436306.
  14. ^ Bourin M, Chue P, Guillon Y (1 March 2001). "Paroxetine: A Review". CNS Drug Reviews. 7 (1): 25–47. doi:10.1111/j.1527-3458.2001.tb00189.x. ISSN 1080-563X. PMC 6741642. PMID 11420571.

© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search